Abstract
The understanding, care and treatment of newborns born with disorders of sex development conditions have evolved considerably over the last few decades. Biological assessment of atypical genitalia is based on a structured sequence of endocrine and genetic investigations, starting from a suitable history and a complete examination of the external genital anatomy. Investigations are particularly relevant in 46,XY DSD where the diagnostic yield is less successful than in the 46,XX conditions. The era of next generation sequencing is increasingly being applied to investigate complex medical diseases of unknown cause, including DSD. The challenge for health professionals will lie in integrating vast amounts of genetic information with phenotypes and counselling families appropriately. Regarding those who require evaluation before gender assignment is made, each “generation” of approach reflects the contemporary biological, social and psychological understanding. The most recent generation needs to consider the significantly changed societal viewpoints regarding the acceptance and expansion beyond a binary perception of sexuality. This together with advances in genetic etiologies, surgical refinements and psychological support should result in better care and quality of life (QoL) outcomes for patients with these conditions.
This is a preview of subscription content, log in via an institution.
References
Abacı A, Çatlı G, Berberoğlu M (2015) Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development. J Pediatr Endocrinol Metab 28(9–10):1019–1027. doi:10.1515/jpem-2014-0522
Achermann JC, Hughes IA (2007) Disorders of sex development. In: Kronenberg H, Melmed S, Polonsky K, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia
Ahmed SF, Bryce J, Hiort O (2014) International networks for supporting research and clinical care in the field of disorders of sex development. In Understanding differences and disorders of sex development (DSD). Endocrine development, vol 27. pp 284–292 https://www.karger.com/Article/Abstract/363676
Ahmed SF, Achermann JC, Arlt W et al (2016) Society for endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (revised 2015). Clin Endocrinol 84:771–788
Ainsworth C (2015) Sex redefined. Nature 518(7539):288–291. http://www.ncbi.nlm.nih.gov/pubmed/25693544
Austin J, Tamar-Mattis A, Mazur T et al (2011) DSD: when and how to tell the patient. Pediatr Endocrinol Rev 8:213–217
Balsamo A, Cacciari E, Piazzi S et al (1996) Congenital adrenal hyperplasia: neonatal mass screening compared to clinical diagnosis only in the Emilia-Romagna Region of Italy (1980–1995). Pediatrics 98:362–367
Balsamo A, Baldazzi L, Menabò S, Cicognani A (2010) Impact of molecular genetics on congenital adrenal hyperplasia management. Sex Dev 4:233–248
Bertelloni S, Baroncelli GI, Ghirri P et al (2001) Hormonal treatment for unilateral inguinal testis: comparison of four different treatments. Horm Res 55:236–239
Bertelloni S, Scaramuzzo RT, Parrini D et al (2007) Early diagnosis of 5-alpha-reductase deficiency in newborns. Sex Dev 1:147–151
Bertelloni S, Balsamo A, Giordani L et al (2009) 17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence. J Endocrinol Invest 32:666–670
Bertelloni S, Baldinotti F, Russo G, Ghirri P, Dati E, Michelucci A, Moscuzza F, Meroni S, Colombo I, Sessa MR, Baroncelli GI (2016) 5α-reductase-2 deficiency: clinical findings, endocrine pitfalls, and genetic features in a large Italian cohort. Sex Dev 10:28–36
Biason-Lauber A (2010) Control of sex development. Best Pract Res Clin Endocrinol Metab 24:163–186
Biason-Lauber A, Chaboissier MC (2015) Ovarian development and disease: the known and the unespected. Semin Cell Dev Biol 45:59–67
Biason-Lauber A, Miller WL, Pandey AV, Flück CE (2013) Of marsupials and men: backdoor dihydrotestosterone synthesis in male sexual differentiation. Mol Cell Endocrinol 371:124–132. http://www.ncbi.nlm.nih.gov/pubmed/23376007
Brain CE, Creighton SM, Mushtaq I et al (2010) Holistic management of DSD. Best Pract Res Clin Endocrinol Metab 24:335–354
Burkhard FZ, Parween S, Udhane SS, Fluck CE, Pandey AV (2016) P450 oxidoreductase deficiency: analysis of mutations and polymorphisms. J Steroid Biochem Mol Biol. doi:10.1016/j.jsbmb.2016.04.003
Cools M, Drop SL, Wolffenbuttel KP et al (2006) Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 27:468–484
Cools M, Wolffenbuttel KP, Drop SLS, Oosterhuis JW, Looijenga LH (2011) Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev 5:167–180
Cools M, Simmonds M, Elford S, Gorter J, Ahmed SF, D’Alberton F, Springer A, Hiort O; Management Committee of the European Cooperation in Science and Technology Action BM1303 (2016) Response to the council of Europe human rights commissioner’s issue paper on human rights and intersex people. Eur Urol. pii: S0302-2838(16)30179-8. doi:10.1016/j.eururo.2016.05.015. [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/27210458
D’Alberton F (2010) Disclosing DSD and opening the doors. Sex Dev 4:304–309
D’Alberton F et al (2015) Quality of life and psychological adjustment of women living with 46, XY differences of sex development. J Sex Med 12(6):1440–1449
di Clemente N, Belville C (2006) Anti-Müllerian hormone receptor defect. Best Pract Res Clin Endocrinol Metab 20:599–610
Elsheikh M, Dunger DB, Conway GS, Wass JA (2002) Turner’s syndrome in adulthood. Endocr Rev 23:120–140
Ferraz-de Souza B, Lin L, Acherman JC (2011) Steroidogenic Factor 1 (SF1, NR5A1) and human diseases. Mol Cell Endocrinol 336:198–205
Ghirri P, Scaramuzzo MR, Greggio N, Salerno MC (2015) (Italian) Protocollo diagnostico e management in età neonatale. In http://www.gruppodistudio-it-dsd.org/diffsvilup/32_protoc_neonatale_dsd.pdf
Ghirri P, Ciulli C, Vuerich M et al (2002) Incidence at birth and natural history of cryptorchidism: a study of 10,730 consecutive male infants. J Endocrinol Invest 25:709–715
Ghirri P, Scaramuzzo RT, Bertelloni S et al (2009) Prevalence of hypospadias in Italy according to severity, gestational age and birthweight: an epidemiological study. Riv Ital Pediatr 35:18
Gillam LH, Hewitt JK, Warne GL (2010) Ethical principles for the management of infants with DSD. Horm Res Paediatr 74:412–418
Hewitt J, Zacharin M (2015) Hormone replacement in disorders of sex development: current thinking. Best Pract Res Clin Endocrinol Metab 29:437e447
Hsu LY, Benn PA (1999) Revised guidelines for the diagnosis of mosaicism in amniocytes. Prenat Diagn 19:1081–1082
Hughes IA, Deeb A (2006) Androgen resistance. Best Pract Res Clin Endocrinol Metab 20:577–598
Hughes IA, Lim HN, Martin H et al (2001) Developmental aspects of androgen action. Mol Cell Endocrinol 185:33–41
Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT (2007) Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab 21:351–365
Imperato-McGinley J, Zhu YS (2002) Androgens and male physiology the syndrome of 5-alpha-reductase-2 deficiency. Mol Cell Endocrinol 198:51–59
Janjua NR, Frederiksen H, Skakkebaek NE et al (2008) Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. Int J Androl 31:118–130
Joint LWPES/ESPE CAH Working Group (2002) Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins pediatric endocrine society and the European society for paediatric endocrinology. J Clin Endocrinol Metab 87:4048–4053
Jones ME, Boon WC, McInnes K et al (2007) Recognizing rare disorders: aromatase deficiency. Nat Clin Pract Endocrinol Metab 3:414–421
Jurgensen M, Kleinemeier E, Lux A et al (2010) Psychosexual development in children with DSD: results from the German clinical evaluation study. J Pediatr Endocrinol Metab 23:565–578
Kalfa N, Philibert P, Baskin LS, Sultan C (2011) Hypospadias: interactions between environment and genetics. Mol Cell Endocrinol 335:89–95
Kleinemeier E, Jurgensen M, Lux A et al (2010) Psychological adjustment and sexual development of adolescents with DSD. J Adolesc Health 47:463–471
Kolesinska Z, Ahmed SF, Niedziela M, Bryce J, Molinska-Glura M, Rodie M, Jiang J, Sinnott RO, Hughes IA, Darendeliler F, Hiort O, van der Zwan Y, Cools M, Guran T, Holterhus PM, Bertelloni S, Lisa L, Arlt W, Krone N, Ellaithi M, Balsamo A, Mazen I, Nordenstrom A, Lachlan K, Alkhawari M, Chatelain P, Weintrob N (2014) Changes over time in sex assignment for disorders of sex development. Pediatrics 134(3):e710–e715. doi:10.1542/peds.2014-1088. Epub 2014 Aug 4. http://www.ncbi.nlm.nih.gov/pubmed/25092939
Lajic S, Nordenström A, Hirvikoski T (2008) Long-term outcome of prenatal treatment of congenital adrenal hyperplasia. Endocr Dev 13:82–98
Latronico AC, Arnhold IJ (2006) Inactivating mutations of LH and FSH receptors–from genotype to phenotype. Pediatr Endocrinol Rev 4:28–31
Lee YS, Cheng AW, Ahmed SF (2007) Genital anomalies in Klinefelter’s syndrome. Horm Res 68:150–155
Mac Laughlin DT, Danahoe PK (2004) Sex determination and differentiation. N Engl J Med 350:367–378
Manna PR, Stocco DM (2005) Regulation of the steroidogenic acute regulatory protein expression: functional and physiological consequences. Curr Drug Targets Immune Endocr Metabol Disord 5:93–108
Massart F, Saggese G (2009) Sex steroidal targets & genetic susceptibility to idiopathic cryptorchidism. Pediatr Endocrinol Rev 6:481–490
McCarty MM (2008) Estradiol and the developing brain. Physiol Rev 88:91–124
Menabò S, Balsamo A, Nicoletti A et al (2008) Three novel AMH gene mutations in a patient with persistent müllerian duct syndrome and normal AMH serum dosage. Horm Res 70:124–128
Menabò S, Polat S, Baldazzi L, Kulle AE, Holterhus PM, Grötzinger J, Fanelli F, Balsamo A, Riepe FG (2014) Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations. Eur J Hum Genet 22(5):610–616. doi:10.1038/ejhg.2013.197. Epub 2013 Sep 11. PubMed PMID: 24022297; PubMed Central PMCID: PMC3992560. http://www.ncbi.nlm.nih.gov/pubmed/24022297
Mendonca BB, Domenice S, Arnhold IJP, Costa EMF (2009) 46, XY disorders of sex development (DSD). Clin Endocrinol 70:173–187
Meyer-Bahlburg HFL et al (2016) Gender assignment, reassignment and outcome in disorders of sex development: update of the 2005 consensus conference. Horm Res Paediatr 85(2):112–118
Migeon CJ, Berkovitz DG, Brown TR (1994) Sexual differentiation and ambiguity. In: Kappy MS, Blizzard RM, Migeon CJ (eds) The diagnosis and treatment of endocrine disorders in childhood and adolescence, 4th edn. Thomas, Springfield
Nabhan ZM, Lee PA (2007) Disorder of sex development. Curr Opin Obstet Gynecol 19:440–445
Nielsen J, Wohlert M (1991) Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87:81–83
Nihoul-Fekete C, Lortat-Jacob S, Cachin O, Josso N (1984) Preservation of gonadal function in true hermaphroditism. J Pediatr Surg 19:50–55
Polizzi A, Balsamo A, Bal MO, Taruscio D (2014) Rare diseases research and practice. Endocr Dev 27:234–256. http://www.ncbi.nlm.nih.gov/pubmed/25247660
Saggese G, Ghirri P, Gabrielli S, Cosenza GC (1989) Hormonal therapy for cryptorchidism with a combination of human chorionic gonadotropin and follicle-stimulating hormone. Success and relapse rate. Am J Dis Child 143:980–982
Samtani R, Bajpai M, Ghosh PK, Saraswathy KN (2010) SRD5A2 gene mutations – a population-based review. Pediatr Endocrinol Rev 8(1):34–40
Sax L (2002) How common is intersex? A response to Anne Fausto- Sterling. J Sex Res 39:174–178
Schweizer K et al (2014) Gender experience and satisfaction with gender allocation in adults with diverse intersex conditions (divergences of sex development, DSD). Psychol Sex 5(1):56–82
Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY (2014) Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation. J Perinat Med 42(1):121–127. http://www.ncbi.nlm.nih.gov/pubmed/23989111
Shearer BM, Thorland EC, Gonzales PR, Ketterling RP (2007) Evaluation of a commercially available focused aCGH platform for the detection of constitutional chromosome anomalies. Am J Med Genet A 143:2357–2370
Simm D, Degenhardt K, Gerdemann C et al (2008) Chronological age of patients with Turner syndrome at diagnosis. Klin Padiatr 220:16–20
Slowikowska-Hilczer J, Szarras-Czapnik M, Wolski JK, Oszukowska E, Hilczer M, Jakubowski L, Walczak-Jedrzejowska R, Marchlewska K, Filipiak E, Kaluzewski B, Baka-Ostrowska M, Niedzielski J, Kula K (2015) The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients. Folia Histochem Cytobiol 53(3):218–226
Speiser PW (2007) Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia. Horm Res 68(Suppl 5):90–92
Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349:776–788
Telvi L, Lebbar A, Del Pino O (1999) 45,X/46,XY mosaicism: report of 27 cases. Pediatrics 104(2 Part 1):304–308
Toppari J (2008) Environmental endocrine disrupters. Sex Dev 2:260–267
Turcu AF, Auchus RJ (2015) The next 150 years of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 153:63–71
Warne GL (2008) Long-term outcome of disorders of sex development. Sex Dev 2:268–277
Warne G, Raza J (2008) Disorders of sex development (DSDs), their presentation and management in different cultures. Rev Endocr Metab Disord 9:227–236
Wittassek M, Angerer J (2008) Phthalates: metabolism and exposure. Int J Androl 31:131–138
Wohlfahrt-Veje C, Main KM, Skakkebæk NE (2009) Testicular dysgenesis syndrome; fetal origin of adult reproductive problems. Clin Endocrinol (Oxf) 71:459–465
Yamada G, Satoh Y, Baskin LS, Cunha GR (2003) Cellular and molecular mechanisms of development of external genitalia. Differentiation 71:445–470
Zimmermann B, Zhong XY, Holzgreve W et al (2007) Real-time quantitative polymerse chain reaction measurement of male fetal DNA in maternal plasma. Methods Mol Med 132:43–49
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this entry
Cite this entry
Balsamo, A. et al. (2016). Disorders of Sexual Development in Newborns. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Cham. https://doi.org/10.1007/978-3-319-18159-2_260-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-18159-2_260-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-18159-2
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Disorders of Sexual Development in Newborns- Published:
- 21 December 2017
DOI: https://doi.org/10.1007/978-3-319-18159-2_260-2
-
Original
Disorders of Sexual Development in Newborns- Published:
- 05 January 2017
DOI: https://doi.org/10.1007/978-3-319-18159-2_260-1